๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Should oral bisphosphonates be standard of care in women with early breast cancer?

โœ Scribed by Mark Clemons; Sunil Verma

Publisher
Springer US
Year
2005
Tongue
English
Weight
155 KB
Volume
90
Category
Article
ISSN
0167-6806

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Summary of aromatase inhibitor clinical
Summary of aromatase inhibitor clinical trials in postmenopausal women with early breast cancer
โœ Aman U. Buzdar; R. Charles Coombes; Paul E. Goss; Eric P. Winer ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 115 KB

Five years of adjuvant therapy with tamoxifen was considered the gold-standard treatment for postmenopausal women with estrogen receptor-positive breast cancer for many years. Data from a core group of clinical trials investigating the safety and efficacy of aromatase inhibitors (AIs) have challenge

Changing trends in the decision-making p
Changing trends in the decision-making preferences of women with early breast cancer
โœ L. J. M. Caldon; S. J. Walters; M. W. R. Reed ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 113 KB

## Abstract ## Background Previous studies have indicated a predominance of passive decision-making styles among women with early-stage breast cancer in the UK offered a choice between breast-conserving surgery (BCS) and mastectomy. The aim of this study was to determine current decision-making st